Madrigal Pharmaceuticals, Inc.
MDGL
$301.66
-$6.12-1.99%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 46.07% | 329.79% | 254.47% | 221.44% | 76.75% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 337.65% | 569.05% | 370.98% | 676.70% | 21.39% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 62.08% | 351.72% | 261.98% | 224.18% | 76.35% |
|
|||||
Total Current Assets | 62.08% | 351.72% | 261.98% | 224.18% | 76.35% |
Net Property, Plant & Equipment | 40.57% | 91.58% | 263.86% | 185.67% | 171.49% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 62.71% | 351.02% | 263.61% | 225.55% | 76.67% |
|
|||||
Total Accounts Payable | 55.48% | 177.87% | -48.71% | 77.51% | 17.67% |
Total Accrued Expenses | 38.58% | 58.58% | 41.40% | 7.83% | -1.62% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 86.53% | 71.15% | 35.52% | -17.00% | -12.46% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 42.79% | 78.44% | 25.53% | 16.26% | 2.29% |
|
|||||
Total Current Liabilities | 42.79% | 78.44% | 25.53% | 16.26% | 2.29% |
Long-Term Debt | 1.81% | 2.06% | 17.49% | 38.31% | 134.29% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -14.17% | -11.11% | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 22.38% | 37.27% | 21.97% | 26.99% | 42.40% |
|
|||||
Common Stock & APIC | 46.80% | 102.08% | 102.88% | 96.24% | 50.09% |
Retained Earnings | -34.86% | -42.37% | -45.36% | -42.74% | -38.81% |
Treasury Stock & Other | 0.00% | 3,126.19% | -313.48% | -100.00% | 1,562.50% |
Total Common Equity | 86.11% | 3,392.99% | 728.09% | 466.66% | 105.35% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 86.11% | 3,392.99% | 728.09% | 466.66% | 105.35% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 86.11% | 3,392.99% | 728.09% | 466.66% | 105.35% |
|